Summary:
A Phase 2, Multi-center, Randomized, Double-Blind, ParallelGroup, Dose-Finding Study to Assess the Effect of Four Doses of MM-120 for the Treatment of Anxiety Symptoms.
Qualified Participants Must:
• Be 18-74 years old
•
Have a BMI of 18-38 mg/kg2
•
Be diagnosed with generalized anxiety disorder (GAD)
Qualified Participants May Receive:
- Up to $1,300 for time and tavel
- No insurance needed and transportation available